BioPartner UK is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. It has a membership of core life Science companies that represent British expertise keen to do business overseas. Biopartner leads the UK Delegation to several partnering conferences each year, and through its partnerships, offers discounts to all UK companies with higher rates and benefits to its members.
Scottish Development International
Scottish Development International offers free and confidential support to foreign companies who would like to identify commercial, clinical or academic partners in Scotland. SDI can also offer a wide range of investor support services for companies expanding in Europe.
The Scottish Life Sciences sector consists of over 650 organisations employing over 32,500 people with particular strengths in cell and gene therapy, pharmaceutical services, digital health and clinical translational medicine.
Scotland has a strong cluster of expert, innovative and ambitious companies delivering outsourcing solutions for biopharmaceutical companies globally. This includes both multi-national and niche CROs, innovative drug delivery and formulation specialists and manufacturing services that span drug development.
Scotland is also in the top three centres for drug discovery and development in the UK and has a streamlined process for establishing clinical trials with fast approval times.
Mrs Emily LekkasInternational Senior Executive
Ms Katharina KraehahnInternational Senior Executive
United Life Sciences
United Life Sciences (ULS) is a strategic partnership representing over 1240 life science and healthcare organisations across the UK and internationally. The partnership was formed by four Founding Partners: the BioIndustry Association (BIA), Bionow, BioPartner UK and One Nucleus (ON) in 2014 and MediWales joined in 2015.
The ULS collaboration has member and the wider UK life science sector at the heart of its purpose and is the basis for all joint activities. We strive to avoid duplication of effort and coordinate the founders' activities whilst recognising each other's areas of strength so that member companies can benefit from more effective and coherent sector support.
Since 2012 ULS partners have worked together on a range of activities - including the creation and publication of a UK Life Science Manifesto 2015 - 2020, which is aimed at all political parties, and calls for the Biomedical Catalyst scheme to be continued in the interest of the nation's health and wealth: click here to download the 2015 updated BMC report. ULS has also hosted a number of joint events both in the UK and overseas, and will be undertaking further joint initiatives plus providing cost effective attendance at each other's events to maximise the international impact of the UK. Discounts are available to each other's members for 3 of each of our major events so please check with your membership organisation for details.